Recurrent Colon Carcinoma Completed Phase 1 / 2 Trials for Capecitabine (DB01101)

Also known as: Carcinoma colon recurrent / Colon carcinoma recurrent / Colon cancer recurrent

IndicationStatusPhase
DBCOND0047445 (Recurrent Colon Carcinoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02393755Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerTreatment